Comparative study of protective effects of Cortexin, Cerebrolysin and Actovegin on memory impairment, cerebral circulation and morphological changes in the hippocampus of rats with chronic brain ischemia-Reference-Cited by-同舟云学术

Comparative study of protective effects of Cortexin, Cerebrolysin and Actovegin on memory impairment, cerebral circulation and morphological changes in the hippocampus of rats with chronic brain ischemia

Published:2020 Issue:8 Volume:120 Page:83
ISSN:1997-7298
Container-title:Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova
language:en
Short-container-title:Z. nevrol. psikhiatr. im. S.S. Korsakova

Author:

Tyurenkov I.N.,Kurkin D.V.,Kalatanova A.V.,Dorotenko, A.R.,Bakulin, D.A.,Morkovin E.I.,Verholyak D.V.,Gorbunova Yu.V.,Atapina N.V.,Smirnov A.V.,Schmidt M.V.

Publisher

Media Sphere Publishing Group

Subject

Psychiatry and Mental health,Clinical Neurology

Reference14 articles.

1. The efficacy of combination therapy with mexidol and cerebrolysin in chronic cerebral ischemia

2. Cortexin. Molecular mechanisms and targets of neuroprotective activity

3. Masliah E, Díez-Tejedor E. The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders. Drugs Today (Barc). 2012;48(Suppl A):3-24

4. Cerebrolysin Reduces Astrogliosis and Axonal Injury and Enhances Neurogenesis in Rats After Closed Head Injury

5. ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin)

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Use of Animal Neuropeptides in the Treatment of Neurological Diseases;Neuroscience and Behavioral Physiology;2024-02

2. Results of a pilot study of the structure and evaluation of the therapy for chronic sleep disorders in comorbid patients with chronic cerebral ischemia;S.S. Korsakov Journal of Neurology and Psychiatry;2024

3. Late onset psychosis treatment with adjunctive medicines;Frontiers in Psychiatry;2023-12-21

4. The use of neuropeptides of animal origin in the treatment of neurological diseases;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2023

5. Drug Synergism as the Basis of Rational Neuroprotection;Neuroscience and Behavioral Physiology;2022-10